In a similar manner, the study by Valentin Zumstein et al. [27] at a single center emphasized the efficacy of immunohistochemical screening to detect Lynch syndrome, revealing that 15.0% of CRC tumors demonstrated loss of MMR protein expression and 6.0% of CRCs were potential Lynch syndrome cases. This evidence concerns the gene MRC1 and Lynch syndrome.